Bleakley Financial Group LLC lifted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 30.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 41,691 ...
Maravai Lifesciences Holdings Inc (MRVI) stock has reached a new 52-week low, touching down at $4.19, representing a steep 64% decline from its 52-week high of $11.55. The $1.09 billion market cap ...
In a report released today, Brandon Couillard from Wells Fargo maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research ...
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,002 put options on the company.
RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on February 4 and set a ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...